Teladoc Health, Inc. (TDOC) DCF Valuation

Teladoc Health, Inc. (TDOC) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Teladoc Health, Inc. (TDOC) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Teladoc Health, Inc.'s (TDOC) financial prospects like an expert! This (TDOC) DCF Calculator comes with pre-filled financial data and offers full flexibility to modify revenue growth, WACC, margins, and other crucial assumptions to align with your predictions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 553.3 1,094.0 2,032.7 2,406.8 2,602.4 3,969.0 6,053.4 9,232.2 14,080.4 21,474.7
Revenue Growth, % 0 97.71 85.81 18.41 8.13 52.51 52.51 52.51 52.51 52.51
EBITDA -41.5 -438.0 -84.7 -13,383.4 154.0 -1,157.3 -1,765.0 -2,691.8 -4,105.4 -6,261.4
EBITDA, % -7.5 -40.04 -4.17 -556.06 5.92 -29.16 -29.16 -29.16 -29.16 -29.16
Depreciation 39.0 78.1 219.6 270.6 351.3 394.7 602.0 918.2 1,400.4 2,135.7
Depreciation, % 7.04 7.14 10.8 11.24 13.5 9.95 9.95 9.95 9.95 9.95
EBIT -80.4 -516.1 -304.3 -13,654.1 -197.3 -1,462.7 -2,230.9 -3,402.4 -5,189.1 -7,914.2
EBIT, % -14.54 -47.18 -14.97 -567.3 -7.58 -36.85 -36.85 -36.85 -36.85 -36.85
Total Cash 517.1 786.6 896.0 918.2 1,123.7 2,308.1 3,520.1 5,368.7 8,188.0 12,487.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 56.9 169.3 169.0 210.6 230.1
Account Receivables, % 10.29 15.47 8.31 8.75 8.84
Inventories .0 56.5 73.1 56.3 29.5 97.1 148.1 225.9 344.5 525.5
Inventories, % 0.000000181 5.16 3.6 2.34 1.13 2.45 2.45 2.45 2.45 2.45
Accounts Payable 9.1 46.0 47.3 47.7 43.6 93.9 143.2 218.4 333.2 508.1
Accounts Payable, % 1.64 4.21 2.32 1.98 1.68 2.37 2.37 2.37 2.37 2.37
Capital Expenditure -10.9 -26.0 -63.9 -172.8 -156.3 -164.2 -250.4 -381.9 -582.4 -888.3
Capital Expenditure, % -1.97 -2.38 -3.15 -7.18 -6.01 -4.14 -4.14 -4.14 -4.14 -4.14
Tax Rate, % -0.34607 -0.34607 -0.34607 -0.34607 -0.34607 -0.34607 -0.34607 -0.34607 -0.34607 -0.34607
EBITAT -72.7 -434.7 -339.2 -13,650.3 -198.0 -1,388.2 -2,117.2 -3,229.0 -4,924.7 -7,510.9
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -92.5 -514.5 -198.5 -13,576.8 .2 -1,355.0 -1,982.6 -3,023.8 -4,611.7 -7,033.5
WACC, % 6.33 6.19 6.55 6.55 6.55 6.43 6.43 6.43 6.43 6.43
PV UFCF
SUM PV UFCF -14,274.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -7,174
Terminal Value -161,787
Present Terminal Value -118,450
Enterprise Value -132,724
Net Debt 469
Equity Value -133,193
Diluted Shares Outstanding, MM 165
Equity Value Per Share -809.30

What You Will Get

  • Comprehensive TDOC Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Real-Time Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Evaluate various scenarios to assess Teladoc's future performance.
  • User-Friendly Interface: Designed for professionals while remaining approachable for newcomers.

Key Features

  • Comprehensive Data: Teladoc Health’s historical financial statements and pre-filled projections.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Analysis: Monitor Teladoc Health’s intrinsic value recalculating instantly.
  • Intuitive Visualizations: Dashboard charts present valuation outcomes and essential metrics.
  • Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.

How It Works

  • 1. Access the Template: Download and open the Excel file featuring Teladoc Health, Inc.'s (TDOC) preloaded data.
  • 2. Modify Assumptions: Adjust key variables such as growth rates, WACC, and capital expenditures.
  • 3. View Results Instantly: The DCF model automatically computes intrinsic value and NPV.
  • 4. Explore Scenarios: Evaluate various forecasts to assess different valuation results.
  • 5. Present with Confidence: Deliver expert valuation insights to enhance your decision-making.

Why Choose Teladoc Health, Inc. (TDOC)?

  • Convenient Access: Get healthcare services anytime, anywhere with just a few clicks.
  • Enhanced Care Quality: Access to a network of licensed professionals ensures high-quality medical advice.
  • Personalized Health Solutions: Tailor your healthcare experience to meet your individual needs and preferences.
  • User-Friendly Platform: Intuitive design makes it easy to navigate and utilize our services effectively.
  • Proven Track Record: Trusted by millions for delivering reliable and efficient telehealth solutions.

Who Should Use This Product?

  • Healthcare Professionals: Understand telehealth trends and improve patient engagement using real-time data.
  • Researchers: Utilize advanced models to analyze the impact of telemedicine on healthcare delivery.
  • Investors: Evaluate your investment strategies and assess valuation metrics for Teladoc Health, Inc. (TDOC).
  • Market Analysts: Enhance your analysis with a customizable financial model tailored for the telehealth sector.
  • Health Tech Entrepreneurs: Learn from the valuation approaches used by leading telehealth companies like Teladoc.

What the Template Contains

  • Preloaded TDOC Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.